IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Curtis Dean who wrote (228)	2/7/1998 10:32:00 PM
From: Manny Gugliuzza	Read Replies (1) of 1510

forget about insider sales unless they approach average daily volume. >it seems by now they should know if their drug works or not!< it seems by now the FDA should know if immune's remune works or not? this what i interpret that sentence to read. just because the results are all good in the past trials, which have now dragged on longer to include the triple drug combo so the FDA would at least consider approval, it must be PROVEN to the FDA doctors,who are right in on these trials or at least the large patient numbered ones i have read about, that the effect that remune is having on the immune system is creating the response they are now seeing wether in conjunction with triple therapy or not. i will not give my understanding of the immune system, t-cell lymphocytic response to remune here or you will be exhausted and me. dr jonas salk et al have written this out in detail for you to read understanding is difficult. the immune system is the answer, remune is proving this slowly, but is being dragged down by the triple drug therapy which immune needs besides the help from the larger drug companies that produce these drugs to get approval and then they can go on. in six weeks we will know which company wants this therapy and how much power they have to push the approval through. this is what the company says. if we do not see action by then those single number stock options may look expensive.... some good technicals from the weekly second opinion are that the resistance level of 9.76 was broken with the close at 10 and the buy back stop has been lowered from 11.5 to 11.375. not much but please check this site for other fundamental and technicals that you may find useful and or helpful to post here. stocksmartpro.com individual institutional holdings are found under the companies name. this site is free for 10 days only it is expansive and expensive use it timely and wisely. ar.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next